Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Knowing when to adjust your financial plan can significantly impact your financial success. Learn key indicators for making timely adjustments.
23,637 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Georgia and Tether announce a plan to deploy GEL₮, a stablecoin tied to the Georgian lari, designed to ride private p...
Solana (HSDT) 2026 earnings reveal momentum in Q1 amid growing on-chain activity and ecosystem expansion. This guide ...
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
A prominent billionaire asserts the market is underestimating how far the Federal Reserve may go with rate cuts. This...
The AI boom isn’t over. If you felt you missed the first wave, these three resilient stocks deliver real AI leverage,...
Tesla is ending production of its flagship Model S and Model X. This article breaks down the real reasons behind the ...
Thomas Siebel’s return as C3.AI CEO could reshape sales strategy and investor sentiment. This article breaks down wha...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
An insider at Mirion Technologies reduced his stake by roughly $165,000 in a May 2026 move. This article explains how...
Cava's yearly revenue just crossed the $1 billion mark, signaling a major milestone for the fast-casual chain. This a...
Even as households feel the bite of high prices and sticky inflation, many companies keep beating earnings estimates....